Waldencast plc revenue by segment MLKWF

Waldencast plc splits its revenue 2 ways in its filings. By operating segments, the largest line in fiscal 2025, which ended Dec 31, 2025 was Obagi Skincare at $161.6 million, 59% of the total. By sales mix, the largest line in fiscal 2025, which ended Dec 31, 2025 was Product at $157.7 million, 58% of the total.

USD in millions. The percent under a figure is the change from the year before.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2021
Revenue
272
274
218
142
Operating segments
Obagi Skincare
162
+8.3%
share 59.4%
149
+26.9%
share 54.5%
118
share 53.9%
—
Milk Makeup
110
-11.4%
share 40.6%
125
+24.0%
share 45.5%
100
share 46.1%
—
Sales mix
Product
158
+8.9%
share 58.0%
145
+28.5%
share 52.9%
113
-17.6%
share 51.6%
137
share 96.0%
Milk Makeup
110
-11.4%
share 40.6%
125
+24.0%
share 45.5%
100
share 46.1%
—
Royalty
4
-13.0%
share 1.4%
4
-10.7%
share 1.6%
5
-12.4%
share 2.3%
6
share 4.0%
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. More on our methodology.

Company profile

Industry
Perfumes, Cosmetics & Other Toilet Preparations (SIC 2844)
Listed as
MLKMF (OTC), MLKWF (OTC)
Headquarters
London, United Kingdom
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
1840199
Former names
Waldencast Acquisition Corp. (until Jul 27, 2022)

Other Perfumes, Cosmetics & Other Toilet Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.